Circular RNAs (circRNAs) possess valuable characteristics for both diagnosis and treatment of several human cancers including breast cancer (BC). In this study, we combined several systems, biology tools and approaches to identify influential BC circRNAs, miRNAs, and related mRNAs as the members of competing endogenous RNAs (ceRNAs) networks and related RNA binding proteins (RBPs) to study and decipher the BC-triggering biological processes and pathways. Rooting from the identified total of 25 co-differentially expressed circRNAs (DECs) between triple negative (TN) and luminal A subtypes of BC from microarray analysis, five hub DECs (hsa_circ_0003227, hsa_circ_0001955, hsa_circ_0020080, hsa_circ_0001666, and hsa_circ_0065173) and top eleven RBPs (AGO1, AGO2, EIF4A3, FMRP, HuR (ELAVL1), IGF2BP1, IGF2BP2, IGF2BP3, EWSR1, FUS, and PTB) were explored to form the upper stream regulatory elements. All the hub circRNAs were regarded as a super sponge having multiple miRNA response elements (MREs). Then, three BC leading miRNAs (hsa-miR-149, hsa-miR-182, and hsa-miR-383) were also introduced from merging several established ceRNAs networks. The predicted 7-and 8-mer MREs matches between hub circRNAs and leading miRNAs ensured their enduring regulatory capability. The mined downstream mRNAs of the circRNAs-miRNAs network then were presented to STRING database to form the PPI network and to decipher the issue from another point of view. The BC interconnected enriched pathways and processes guarantee the merits of the ceRNAs network's members as targetable therapeutic elements. This study suggested extensive panels of novel therapeutic targets that are in charge of BC progression, hence their impressive role cannot be excluded and needs deeper empirical laboratory designs.
Introduction
Breast cancer (BC) is the most lethal cancer among women worldwide in 2017 [1] . To surpass the anti-cancer treatments' deficiencies, exploitation of all the novel highthroughput data rooting from underlying microlayers of a disease is critical. Competing endogenous RNAs (ceRNAs) are a group of transcripts possessing miRNA response elements (MREs) that are able to regulate each other at the post-transcriptional level [2] . The fundamental core of the ceRNAs' network is based on the transcripts' ratio of affinity and competing for shared miRNAs' MREs [3] . The interrelation between circular RNAs (circRNAs) and mRNAs is pivotal for deciphering this complex, which counts as a novel tracing means to investigate the breast cancer progression and metastasis.
The circRNAs that were surmised to be non-coding are now believed to be translated into proteins [4] . Apropos of being resistant to exonucleases and being more stable due to the lack of cap and poly (A) tails in their structures [5] , they possess myriad noteworthy regulatory roles in cancer genes' expression. They are divided into three subcategories regarding their source of emergence, exonic circRNA (ecRNA), exon-intron circRNA (ElciRNA), and circular intronic circRNA (ciRNA) [6] [7] [8] . In parallel with functioning as Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s1253 9-019-00339 -6) contains supplementary material, which is available to authorized users. transcription and translation regulator, the ecRNAs act as miRNAs sponges enjoying MREs [9] . The circRNA profile of BC versus normal tissues introduces manifold anti-breast cancer controllable targets [10] . Suppression of circIRAK3 leads to down-regulation of FOXC1 through miR-3607-FOXC1 axes and promotes BC cell metastasis [11] . The proliferation and apoptosis of BC cells would be ceased and enhanced, respectively, following ABCB10-circRNA elimination [12] . These and other analogous studies give prominence to the emerging role of circRNAs in controlling BC development.
The miRNAs as the indispensable player of the ceRNAs network with a length of 22 nucleotides attach to 3′ end of mRNAs and act as inhibitors [13, 14] . OncomiRs, including tumor suppressors and tumor triggers, are one of the main targets of breast cancer therapies these days [15] . The overexpression of miR-21 and miR-155, and lost expression of miR-200 and let-7 are responsible for BC progression [16] . The microRNA-34a was authenticated to be a migration inhibitor by targeting EMT transcription factors in BC [17] . The cluster of mir-183/-96/-182 which is under the direct regulation of HSF2 and ZEB1 significantly overexpresses in BC subtypes as oncomiRs. Arresting this cluster triggers BC cell death and subsides BC cells migration and proliferation [18] .
The regulation orchestra would be more completed by RNA-binding proteins (RBPs) that can be sponged by circRNAs. Post-transcriptional modification relies on non-coding RNAs and RBPs forming a complex layer of regulation that its disarrangement results in various hard-to-cure diseases including cancer [19] . As an omnipotent regulatory element, its range of activities differs from pre-mRNA related regulations to RNA turn over and localization, hence has a fundamental impact upon balancing any cellular mechanisms contributing to growth, cell death, immune recognition, and metastasis [20] [21] [22] . It was noted that RNA-binding motif protein 38 (RBM38) as a tumor suppressor RBP exerts it impact through regulating STARD13 ceRNA network and in return inhibits BC metastasis [23] . On the other hand, HuR that counts as tumor trigger enhances Cyclin-E expression and promotes BC progression [24] .
In the current study, we took advantage of a coalescing investigation of both systems' biology and microarray analysis to find differentially expressed circRNAs (DECs) in BC. To narrow down the discovered circRNAs, their corresponding genes were investigated in BC RNA-seq expression data available in Pan-Cancer Analysis Platform of starBase database. The circRNAs that were identically expressed with their corresponding genes were opted for further analyses. Furthermore, probable sponged miRNAs were predicted by Circular RNA Interactome database and filtered by miRCancer to reach the curated BC miRNAs; the related "circRNAs-miRNAs" (ceRNAs) network was formed and visualized in Cytoscape 3.6.0. The network then was investigated to find the hubs of circRNAs and miRNAs by NetworkAnalyzer tool of Cytoscape. The RBP profiling and super sponge confirmation of hub circRNAs were performed by Circular RNA Interactome database. The STRING database then was used to study the interactions of RBPs and their functional annotation. The TargetScan algorithm of DIANAmiRPath3 was then used to spot downstream mRNAs of miRNAs. The predicted mRNAs were filtered by differentially expressed genes (DEGs) identified through microarray analysis. The protein-protein interaction (PPI) network of the remaining mRNAs was established via the STRING database and the hub-clusters were found by MCODE plugin of Cytoscape to form the "miRNAs-mRNAs" (ceRNAs) network. The hubs were then subjected to DAVID 6.7 database to spot enriched GO terms and pathways. The BC leading miRNAs then were spotted through merging the formed networks and experienced other analyses including enrichment analysis and prediction of MREs that were employed by various promising computational biology tools (Fig. 1 ).
Methods

Microarray Analysis to Identify BC DECs and DEGs
The expression dataset of BC circRNAs (GSE101123) was obtained from GEO (https ://www.ncbi.nlm.nih.gov/geo/) database. The dataset contains two important subtypes of BC namely, triple negative (TN) and luminal A. The raw data were imported into R v3.5.2 and analyzed by Limma package and by applying the RMA normalization algorithm. The |log (FC)| > 1 and p value < 0.05 were the established criteria for finding DECs. The common co-expressed DECs between mentioned subtypes were selected for further studies. The gene expression dataset of GSE65194 [25] , which has been used studying the subtypes of TN and luminal A simultaneously, was selected to introduce the DEGs in BC. All the analysis steps were identical but the adjusted p value less than 0.05 and also, the average expression was calculated in case of multiple probes genes. The common coexpressed DEGs were selected for further studies.
The Validation of Discovered DECs
Gene differential expression tool of starBase Pan-cancer analysis platform (https ://starb ase.sysu.edu.cn/panCa ncer. php), having more than 10,000 RNA-seq expression data across 32 types of cancer, was used to filter the DECs regarding their corresponding genes expression in BC. The DECs that were not co-expressed with their genes were removed.
The "circRNAs-miRNAs" Network Establishment and Hubs Identification
The DECs tied miRNAs were predicted by circular RNA interactome (https ://circi ntera ctome .nia.nih.gov/index .html) database and then filtered by curated BC miRNAs of miRCancer database (https ://mirca ncer.ecu.edu/). The "circRNAs-miRNAs" network then was constructed utilizing Cytoscape v3.6.0. The "circRNAs-miRNAs" network was subjected to NetworkAnalyzer tool of Cytoscape and Degree, as the simplest centrality index, and was calculated as the direct number of each gene's neighbors to find the hub circRNAs and hub miRNAs. The hub circRNAs-miRNAs and hub miRNAs-circRNAs networks then were merged intersected together to form the "hub miRNAs-hub circRNAs" network.
Super Sponge Mapping and RBP Profiling
To find out whether the discovered hub circRNAs also count as the super sponge or not, miRNAs target sites were explored through Circular RNA Interactome database.
The Circular RNA Interactome database was used to identify the attachable RBPs to flanking regions and junctions of hub circRNAs [26] . Subsequently, the identified RBPs were subjected to STRING v10.5 (https ://strin g-db.org/) database (interaction score 0.4 and text mining was excluded) to form their interaction network and study the related GO terms, KEGG, and Reactome pathways. The obtained data were plotted using ggplot2 package of R v3.5.2 [27] .
Constructing PPI Network, Exploring Hub Nodes, and Enrichment Analysis
The miRNAs-mRNAs interactions were predicted through TargetScan algorithm of DIANA-miRPath 3 (https ://snf-51578 8.vm.okean os.grnet .gr/index .php?r = mirpath). Then, the obtained mRNAs were filtered by discovered DEGs of the current study. The common ones were selected and subjected to STRING v10.5 database applying the 0.7 as the minimum required interaction score and excluding text mining as the active interaction source to form the PPI network. The resulted network then was The MCODE plugin of Cytoscape [28] , which finds the highly interconnected complexes of a network was used to investigate the hubs within clusters and to form the "mRNAs-miRNAs" network. The clusters were then subjected to enrichment analysis (KEGG pathway and GO term analyses) tool of DAVID 6.7 database (https ://david -d.ncifc rf.gov/).
Characterization and Validation of Leading miRNAs
The common (leading) miRNAs of "miRNAs-mRNAs" and "hub miRNAs-hub circRNAs" networks were compared with 170 BC miRNA-seq data (85 breast cancer samples and 85 adjacent normal ones) of TCGA to monitor their expression status. TCGAbiolinks package of R. v 3.5.2 platform [29] was used to analyze the downloaded data. The miRNAs with FDR < 0.05 and |logFC| > 1 were considered as differentially expressed miRNAs. The leading miRNAs were subjected to miRPathDB v1.1 (https ://mpd.bioin f.uni-sb.de/overv iew.html) for enrichment analysis. The MREs prediction took place upon leading miRNAs and related hub circRNAs by circular RNA interactome database.
Results
Breast Cancer DECs and DEGs
The datasets information was listed in Supplementary 1 (Sheet A). There were 79 and 175 total DECs for luminal A (50 up-regulated and 29 down-regulated circRNAs) and TN (90 up-regulated and 85 down-regulated), respectively. The lists were merged together to find the common co- 
Establishment of circRNAs-miRNAs Network and Hubs Investigation
The total number of 247 miRNAs was predicted by Circular RNA Interactome database for the discovered DECs. After filtering the list with curated BC miRNAs of miRCancer database, the total number was decreased to 44 (Supplementary 2). The "circRNAs-miRNAs" network then was manifested in Cytoscape 3.6 harboring 70 nodes and 112 edges. The network was exposed to hubs investigation by NetworkAnalyzer tool. 20 percent of each type nodes was counted as hubs. A total of five circRNAs (hsa_circ_0001666, hsa_ circ_0001955, hsa_circ_0003227, hsa_circ_0020080, and hsa_circ_0065173) and nine miRNAs (hsa-miR-145, hsamiR-149, hsa-miR-182, hsa-miR-203, hsa-miR-31, hsa-miR-330-3p, hsa-miR-383, hsa-miR-520g, and hsa-miR-873) were derived to be the corresponding hubs. The networks then were merged to form the "hub circRNAs-hub miRNAs" network with 14 nodes and 20 edges ( Fig. 2 and Table 1 ).
Super Sponge Mapping and RBP Profiling
The hub circRNAs [hsa_circ_0003227, hsa_circ_0001955, hsa_circ_0020080, hsa_circ_0001666, and hsa_ circ_0065173] (Table 2 ) count as super sponge because of having multiple binding sites for miRNAs. This feature indicates their potential capability of gene expression regulation through engaging miRNAs ( Fig. 3a and Supplementary 3A).
Following searching BRPs, a total of 26 ones were identified for the five hub circRNAs. The top five RBPs for each circRNA, concerning binding sites, was plotted by ggplot2 package of R v3.5.2 (Fig. 3b) . Their interactions were also investigated by the STRING database and the related network contained 12 nodes (PTBP1 and PTBP2 were listed as PTBP) and 17 edges (Fig. 3c) . The most enriched BP, CC, MF, and pathways were GO:0017148; negative regulation of translation, GO:1990904; ribonucleoprotein complex, GO:0003729; mRNA binding, and hsa03013; RNA transport, hsa05202; transcriptional misregulation in cancer, and HSA-428359; Insulin-like Growth Factor-2 mRNA-binding proteins, respectively (Fig. 3d and Supplementary 3B).
Identified Hubs of PPI Regulatory Network and Annotated GO Terms and Pathways
Filtering the predicted mRNAs of miRNAs by TargetScan algorithm of DIANA-miRPath3 resulted in 393 ones (Supplementary 4; sheet A). With the purpose of exploiting their interactions profoundly, a PPI network (128 nodes and 178 edges) was established and visualized by Cytoscape 3.6.0; 119 nodes and 156 edges were left after merging them with DEGs. To narrow down the PPI network and due to the importance of hubs within clusters, the primary network was divided into seven clusters (scores: 6, 5.556, 4, 3, 3, 3, and 3; overall: 32 nodes and 58 edges) utilizing MCODE plugin applying k score = 2. The resulting PPI network was further combined with related miRNAs to form a precise "hub mRNAs-miRNAs" network (48 nodes and 95 edges; Fig. 4a ). Enrichment analysis including KEGG pathway and GO annotation analyses was implemented by DAVID 6.7 database upon hub genes. The GO terms with a p value less than 0.05 counted as significant and the top five terms of each category were illustrated in Fig. 4b . The most enriched pathway from KEGG was focal adhesion (hsa04510). The most enriched BP, MF, and CC were 'response to DNA damage stimulus; GO:0,006,974', 'ATP binding; GO:0,005,524', and 'nucleoplasm; GO:0,005,654', respectively (Supplementary 4B).
Explored MREs and Enriched Pathways and GO Terms
The networks of "hub mRNAs-miRNAs" and "hub circRNAs-hub miRNAs" were integrated together to find the common (leading) miRNAs. According to the BC miRNAseq data of TCGA database, only three (hsa-miR-149, hsa-miR-182, and hsa-miR-383) out of five miRNAs were expressed significantly different between normal and breast cancer tissues. The enriched pathways and GO terms for the leading miRNAs were also excavated and introduced (Supplementary 4C); the most enriched ones are listed in Table 3 . The MREs between hub circRNAs and leading miRNAs were explored and revealed through circular RNA Interactome database ( Fig. 5 and Supplementary 4D ).
Discussion
RNA splicing eventuates in circular and linear ways producing two kinds of RNAs namely, linear and circular RNAs. Linear splicing engenders linear RNAs through separating introns and joining the exons together, but the back splicing culminates in circRNAs with different lengths considering combinations of introns and exons [30, 31] . The high-throughput methods played major roles in locating and introducing novel circRNAs as paramount upstream regulatory elements of cellular signaling pathways exploiting downstream miRNAs and mRNAs [32, 33] . The circRNA-miRNA-mRNA axis, despite acting as enhancers or silencers, has drawn oncologists' attention, especially in BC in terms of diagnosis and treatment [34] . In the current study, we analyzed the circRNA profiles of luminal A and TN as the most important subtypes of BC and introduced co-expressed ones using high-throughput microarray data of GEO repository. The common co-expressed elements are meticulous targets able to manipulate cancer heterogeneity [35] . The list was narrowed down in search for identical corresponding genes' expression through RNA-seq data. Afterward, the regulatory networks of hub circRNA-hub miRNA, hub miRNAs-hub mRNAs, and RBPs were established to investigate the underlying mechanisms of maintained circRNAs and other introduced factors. Finally, the MREs were revealed between leading miRNAs and super sponge hub circRNAs. The competing endogenous RNAs (ceRNAs) unite to lay the foundations of regulatory networks that affect any biological processes. The circRNAs need additional investigations due to their manifold and ambiguous roles in breast and other human cancers. The main issue is finding the hub circRNAs that have extensive regulatory branches and in this way, avoid pathway compensation ruled by cancer cells in case of manipulating single circRNAs [36] . In the current study, the RNA-seq expression status of circRNAs corresponding genes was used for narrowing down the discovered list. Pertaining to the fact that there are some genes that are unable to produce circRNAs [37] , the corresponding genes seem important both for anti-cancer treatments and diagnosis; especially because of some circRNAs functions as competitors of related mRNAs [38] . All the discovered hub circRNAs were regarded as ecRNAs, capable of regulating gene expression at both levels of post-and at transcription through sponging miRNAs [6] . According to the predicted MREs by Circular RNA Interactome, several 7-and 8-mer matches were found between leading miRNAs and hub circRNAs that promise a secure and stable connection for sponging miRNAs and sequential regulation. This database takes advantage of Targetscan prediction algorithm that finds the probable complementary seeds on miRNAs and MREs of circRNAs [26] . With reference to the fact that alternative splicing undergoes alterations during breast cancer development, the potential matches between miRNAs and circRNAs ought to be as secure as possible to guarantee the true potential of circRNAs in sponging and regulating miRNAs [39, 40] . The ratio of affinity to abundance plays a major role in the MREs profile explaining that despite the higher abundance of 6-mer matches in comparison to 7-and 8-mer matches, the latter ones are more vital for maintaining the connection since they generate better affinity [41, 42] . In connection with this fact that ecRNAs are the only type of circRNAs that has MREs, ciRNAs and EIciRNAs serve as post-transcriptional regulators by modulating mRNA transcription and protein translation [32] .
All the obtained leading miRNAs in the current study except hsa-miR-383 would be up-regulated in BC tissues. The has-miR-194 that is situated at 2q37.3 chromosome was found to be dysregulated in manifold human cancers acting as a double-edged sword [43] ; from manipulating tumor stromal environment by engaging cancer-associated fibroblasts (CAFs) and IL-6 signaling to sensitizing the cancer Fig. 5 The explored MREs between hub circRNAs and leading miRNAs via circular RNA interactome database. The matching sequences upon hub circRNAs and leading miRNAs are, respectively, in blue and red colors cells to chemotherapeutic agents and preventing metastasis and vice versa. In contradiction with the previous studies but kindred to our findings, Tsai et al. [44] have demonstrated that miR-149 was overexpressed in distinct BC groups and explained this lack of correlation by pointing to diverse controllable downstream elements of miRNAs and races. The has-miR-182 of 7q32.2 chromosome is another multifaceted miRNA in cancer; it acts as a tumor silencer in lung and stomach cancers but as a tumor-encouraging element in colon, prostate, and breast cancers. Overexpression of this miRNA especially in the miR-183/96/182 cluster is connected with induction of proliferation and invasion and inhibition of apoptosis through occupying pro-apoptotic Caspase-9 protein [45] . On the other hand, Gilam et al. findings supported the BC anti-metastatic capability of miR-182/miR-96 via palladin down-regulation in SNP-relative manner [46] . Although has-miR-383 loss of expression was shown in several cancers including BC [47] , its underlying mechanisms is not fully investigated and revealed. However, He et al. [48] found that miR-383 down-regulation in brain tumors is followed by AKT pathway initiation and MMP2 up-regulation boosting metastasis.
Trans-acting regulatory RBPs can exert varied regulations over translation of mRNAs based on different cellular conditions and specific RNA motifs and in return, govern biological mechanisms [49] . Through literature search, it was found that among all the discovered RBPs, the empirical mechanisms of EWSR1 and EIF4A3 for BC were not investigated. The other ones' mechanisms were not fully studied and in case of IGFBPs served ambiguous results [50, 51] . As for, the found RBPs seem to be precious targets in controlling BC especially if they will be studied along related proteins in practical networks. The poly pyrimidine tract-binding protein (PTB) is the crucial modulator of splicing and mRNA stability in reaction to cellular imbalances. Whether through cap-or internal ribosome entry site (IRES)-dependent procedures, PTBs' overexpression can fuel BC metastasis and growth [49, 52] . ELAV-like RNA-Binding Protein 1 (ELAVL1; human antigen R (HuR)) as a chief cancerencouraging element was found to promote translation of metastasis, growth, and differentiation factors and cytokines [53] . Its complex mode of activation engages several other regulatory axes such as protein kinase D (PDK) family and heat shock factor 1 (HSF1) and related pathways in BC [54, 55] ; both overexpression and down-regulation of PDK family members in BC ends in tumor progression. HSF1 is accountable for BC promotion and stem cells' regeneration via applying links to long non-coding RNA-21, CTNNB1, and mammalian target of rapamycin (mTOR) [55] . Fused in sarcoma/translocated in liposarcoma (FUS/TLS) undergoes overexpression and in conjunction with nuclear paraspeckle assembly transcript 1 (NEAT1) and miR-548ar provides a stimulating network in BC through manipulating apoptosis [56] . Fragile X mental retardation protein (FMRP) in a three-dimensional nexus with Tudor domain-containing protein 3 (TDRD3) and DNA topoisomerase 3β (TOP3β) functions as a modulator of transcription and translation and enhancer of invasion in BC involving EMT genes [57, 58] . Argonaute (AGO) family can be attached to miRNAs and originate the RNA-induced silencing complex (RISC) to lessen the gene expression. Aberrant expression of AGOs leads to BC progression obedient to accompanied miRNAs and their levels of expression [59] . According to Bellissimo et al. [60] , down-regulation of AGO2/has-miR-145-5p in BC and the resulting metastasis ensued from AGO1/has-miR-145-5p overexpression.
In specifically are related to BC and although studied before, need further care, hence their manipulation with the identified RBPs or circRNAs seem to be an intelligent approach to incapacitate BC progression. The lethality and recurrence of BC are blamed to be caused by metastasis to distant organs, and although the exact undergoing processes of metastasis are not fully understood because of complexity, the impact of epithelial-mesenchymal transition (EMT) clearly outshines and is undeniable [61] . Overexpression of methyl-CpG-binding protein (MeCP2) widely known as an oncogenic epigenetic modulator relevant to BC and acts in line with RAS, MAPK, and PI3K pathways to the extent that its down-regulation would be compensated by RAS overexpression in TN subtype [62] . Another metastasis inducer called A disintegrin and metalloprotease domain-containing protein 12 (ADAM-12) would be silenced by the regulatory axis of Z-DNA/MeCP2/NF1. In BC, lower expression of Z-DNA forming negative regulatory element (NRE) leads to its disunion from MeCP2, hence promoting EMT-related metastasis following ADAM-12 up-regulation [63] . The Notch signaling cooperates diverse panels of all the cancer-promoting pathways (BC stem cell, Hedgehog, Wnt, HER/ErbB, PDGF/PDGFR, TGF-β and etc.), inflammatory and angiogenesis pathways (NF-κB signaling, Leptin signaling, EGF/VEGFR-2 signaling, and HIF signaling) and all cellular processes [64] . Up-regulation of Notch receptors (Notch1, Notch3, and Notch4) culminates in a BC progression engaging Notch1-JAG1, RAS, and TGF-β1 [65] [66] [67] [68] . In connection with the aforementioned vast characteristics of the Notch signaling, one can reasonably conclude the value of its targeting by modulating every means to control BC.
3
The RBPs are also beneficial for targeting Runt-related transcription factor 1 (RUNX1) expression and activity and Ca 2+ pathways. RUNX1 is considered to be a double-edged sword, since both its up-regulation and down-regulation is detectable in BC. Loss of function mutation in cell-specific RUNX1 in luminal subtypes of BC accompanied with TGF-β leads to EMT metastasis [69] ; on the other hand, its up-regulation in TN subtype triggers cancerous cells migration [70] . The Ca 2+ pathway is also another BC triggering player (migration and angiogenesis, proliferation and apoptosis) that needs further and deeper study due to it being subtype specific. Regarding the existing gradient of Ca 2+ on both sides of the plasma membrane and the necessity of upper Ca 2+ concentration in the cytoplasmic environment to instigate proliferation and gene expression, the calcium exchangers and channels or the whole signaling network are advantageous to control BC [71] . It was found that targeting Secretory Pathway Ca 2+ -ATPase 1 (SPCA1) up-regulation led to proliferation subsiding, as it subsequently has an impact on IGF1R production in BC basal-like subtype [72] . In the case of ER + subtypes, it was approved that focusing on calcium pump plasma membrane Ca 2+ -ATPase 2 (PMCA2) overexpression culminates in breaking the apoptosis resistance [73] . These findings strengthen this idea that by modulating circRNAs and integrating the elements of converging mechanisms, a multi-aspect procedure can be developed that would aid in eliminating BC.
With reference to the enriched pathways of leading miRNAs and mRNAs clusters, lots of BC-related pathways were observed that emphasized the significance of discovered regulatory ceRNA axes through the current study for BC eradication. According to this disclosure, there was a common pathway among them, focal adhesion (FA). FAs are the plasma membrane inner structures that contain lots of constitutive proteins including kinases, adaptors, and phosphatases that will be congregated as the result of cells attachment to ECM. FAs are responsible for a wide variety of cellular processes from growth and differentiation to morphology, but their importance in migration is exemplary which is a result of its turn over dominance to broadening [74] . It was demonstrated that focal adhesion kinase (FAK), which is a key player of this pathway, along with being accountable for BC metastasis is also crucial for cell cycle progression engaging a myriad of elements and pathways like MAPK/ ERK, Src, and cyclin D1 [75, 76] . It was also determined that FAs are engrossed in generating and maintenance of breast cancer stem cells (BCSCs), since mammary gland stem cells (MaSCs) have a panel of overexpressed integrins that is followed by FAK activation, anoikis evading (programmed cell death that is the result of detaching from ECM [77] , and self-renewal emergence [78] .
Conclusion
This paper has investigated the high-priority role of ceRNAs regulatory networks in BC and led us to conclude that manipulating the circRNA-miRNA-mRNA or RBP-circRNA-miRNA axes potentially culminates in halting several BC triggering biological processes and pathways. We have found several controllable hubs and targets including circRNAs, miRNAs, RBPs, and mRNAs. This cutting-edge strategy, which is targeting upper hand elements instead of just controlling downstream mRNAs and proteins, needs further wet lab experiments that this group is now working on. Furthermore, the introduced regulatory elements that were obtained through merging several promising bioinformatics tools serve as valuable particles to devise inhibitory procedures against them. The study also covered the explanation of some salient and fundamental pathways in BC and explained the probability effect of controlling RBPs and circRNAs on them, hence suggesting another aspect of ceRNAs networks' regulation.
